1. Home
  2. IOVA vs PATK Comparison

IOVA vs PATK Comparison

Compare IOVA & PATK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • PATK
  • Stock Information
  • Founded
  • IOVA 2007
  • PATK 1959
  • Country
  • IOVA United States
  • PATK United States
  • Employees
  • IOVA N/A
  • PATK N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • PATK Auto Parts:O.E.M.
  • Sector
  • IOVA Health Care
  • PATK Consumer Discretionary
  • Exchange
  • IOVA Nasdaq
  • PATK Nasdaq
  • Market Cap
  • IOVA 2.6B
  • PATK 3.0B
  • IPO Year
  • IOVA N/A
  • PATK N/A
  • Fundamental
  • Price
  • IOVA $7.72
  • PATK $86.96
  • Analyst Decision
  • IOVA Strong Buy
  • PATK Strong Buy
  • Analyst Count
  • IOVA 9
  • PATK 8
  • Target Price
  • IOVA $23.33
  • PATK $93.25
  • AVG Volume (30 Days)
  • IOVA 5.4M
  • PATK 365.5K
  • Earning Date
  • IOVA 11-07-2024
  • PATK 02-06-2025
  • Dividend Yield
  • IOVA N/A
  • PATK 1.91%
  • EPS Growth
  • IOVA N/A
  • PATK 2.83
  • EPS
  • IOVA N/A
  • PATK 4.64
  • Revenue
  • IOVA $90,858,000.00
  • PATK $3,650,747,000.00
  • Revenue This Year
  • IOVA $13,758.71
  • PATK $8.39
  • Revenue Next Year
  • IOVA $171.64
  • PATK $6.49
  • P/E Ratio
  • IOVA N/A
  • PATK $18.96
  • Revenue Growth
  • IOVA 12751.20
  • PATK 0.33
  • 52 Week Low
  • IOVA $6.70
  • PATK $60.67
  • 52 Week High
  • IOVA $18.33
  • PATK $98.90
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 34.10
  • PATK 42.57
  • Support Level
  • IOVA $7.64
  • PATK $89.61
  • Resistance Level
  • IOVA $8.14
  • PATK $91.83
  • Average True Range (ATR)
  • IOVA 0.36
  • PATK 2.67
  • MACD
  • IOVA -0.07
  • PATK -0.40
  • Stochastic Oscillator
  • IOVA 4.26
  • PATK 13.36

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About PATK Patrick Industries Inc.

Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.

Share on Social Networks: